Details of the Drug Formulation (DFM)
General Information of DFM (ID: F13217) | |||||
---|---|---|---|---|---|
Name |
Metformin 500 mg tablet
|
||||
Company |
A-S Medication Solutions; Amneal Pharmaceuticals; McKesson; PD-Rx Pharmaceuticals; Raritan Pharmaceuticals
|
||||
Active Pharmaceutical Ingredient (API) | Metformin | API Info click to show the detail info of this API | |||
Diabetes mellitus | ICD-11: 5A10 | Approved | |||
Drug Inactive Ingredient (DIGs) | |||||
DIG ID | DIG Info | DIG Name | DIG Functional Class | ||
E0NN4I | DIG Info | Dextrin | Binding agent ... | ||
E0M1JK | DIG Info | Propylene glycol | Antimicrobial preservative ... | ||
Full List of Biological Targets of DIG (DBTs) Regulated by DIG(s) in This DFM | ||||||
---|---|---|---|---|---|---|
Oxidoreductase (ORase) | ||||||
DBT Name: Albendazole monooxygenase (CYP3A4) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Interacting DIG | Propylene glycol | |||||
Biological Activity | Inhibition ratio < 20 % (tested by experiment) | [1] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP3A4_HUMAN | |||||
Cell line (CELL) | ||||||
DBT Name: Colon cancer Caco-2 cells (Caco-2) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Interacting DIG | Dextrin | |||||
Biological Activity | Inhibition ratio > 55 % (tested by experiment) | [2] | ||||
Tested Species | Homo sapiens (Human) | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.